^
Association details:
| Biomarker: | EGFR T790M |
|---|---|
| Cancer: | Lung Non-Squamous Non-Small Cell Cancer |
| Drug Class: | PD-L1 inhibitor |
| Direction: | Resistant |
Evidence:
Source:
Title:
379 - Effects on immunotherapy of EGFR mutation subtypes in non-squamous NSCLC
Published date:
03/10/2021
Excerpt:
We retrospectively analyzed 510 patients with non-squamous NSCLC treated with anti-PD-(L)1 monotherapy....A significant difference in survival among the four subtypes of EGFR positive group was observed, mutation of T790M only showed a worse PFS and OS probability compared to the other subtypes (p<0.001 and p = 0.002)…
